Chemoinformaics analysis of gamma-Glutamylaspartic acid
| Molecular Weight | 262.218 | nRot | 8 |
| Heavy Atom Molecular Weight | 248.106 | nRig | 4 |
| Exact Molecular Weight | 262.08 | nRing | 0 |
| Solubility: LogS | -1.299 | nHRing | 0 |
| Solubility: LogP | -4.188 | No. of Aliphatic Rings | 0 |
| Acid Count | 3 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 32.1791 |
| nHD | 5 | BPOL | 17.5169 |
| QED | 0.342 |
| Synth | 2.763 |
| Natural Product Likeliness | 0.654 |
| NR-PPAR-gamma | 0.028 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.124 |
| HIA | 0.077 |
| CACO-2 | -6.57 |
| MDCK | 0.00370073 |
| BBB | 0.101 |
| PPB | 0.140482 |
| VDSS | 0.463 |
| FU | 0.724019 |
| CYP1A2-inh | 0 |
| CYP1A2-sub | 0.008 |
| CYP2c19-inh | 0.03 |
| CYP2c19-sub | 0.026 |
| CYP2c9-inh | 0.055 |
| CYP2c9-sub | 0.599 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.091 |
| CYP3a4-inh | 0.02 |
| CYP3a4-sub | 0.001 |
| CL | 2.727 |
| T12 | 0.709 |
| hERG | 0.006 |
| Ames | 0.018 |
| ROA | 0.002 |
| SkinSen | 0.138 |
| Carcinogencity | 0.022 |
| EI | 0.085 |
| Respiratory | 0.024 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.732587 |